IMRX · Immuneering Corp
$5.21
+0.15 (+2.96%)
At close · Aug 17
Market Cap
$327.37M
Shares
64.70M
Immuneering Corp Earnings Call Transcripts
Every quarterly earnings call for Immuneering Corp (IMRX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY26 · Q1
2026-06-01
Immuneering Corp Q1 FY2026 Earnings Call
Diluted EPS
$-0.21
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q3
2025-11-12
Immuneering Corp Q3 FY2025 Earnings Call
Confident tone
Gemcitabine nab-paclitaxel combination and overall survival
Safety and tolerability / quality of life
Lung cancer and other tumor type expansion
Diluted EPS
$-0.38
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-18
Immuneering Corp Q1 FY2023 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-0.51
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-06
Immuneering Corp Q4 FY2022 Earnings Call
Revenue
$455*
▼ 99.8% YoY Gross margin
100.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–4 of 4 earnings calls
Key facts
CIK
1790340
CUSIP
45254E107
13F (30d)
108 filings
106 filers
Visit website
Investor relations